CASP9 and early-onset autosomal dominant Alzheimer disease: In addition, ATP6V1G3 and COX17 were upregulated in the oxidative phosphorylation pathway and CASP9 was downregulated in the Alzheimer's disease and Parkinson's disease pathways in CKD patients.